EARLY RESPONSE OF BREAST CANCER BONE METASTASES TO CHEMOTHERAPY EVALUATED WITH MR IMAGING
I. Çiray, K H Ahlström, K. Åström, Henrik Lindman(Uppsala University), Jonas Bergh(Karolinska Institutet)
Cited by 27
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k